Page last updated: 2024-09-05

melagatran and flupenthixol

melagatran has been researched along with flupenthixol in 1 studies

Compound Research Comparison

Studies
(melagatran)
Trials
(melagatran)
Recent Studies (post-2010)
(melagatran)
Studies
(flupenthixol)
Trials
(flupenthixol)
Recent Studies (post-2010) (flupenthixol)
185321938018

Protein Interaction Comparison

ProteinTaxonomymelagatran (IC50)flupenthixol (IC50)
Ubiquitin carboxyl-terminal hydrolase 1Homo sapiens (human)7
Potassium channel subfamily K member 2Homo sapiens (human)2
DRattus norvegicus (Norway rat)0.003
D(3) dopamine receptorRattus norvegicus (Norway rat)0.003
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.003
D(4) dopamine receptorRattus norvegicus (Norway rat)0.003
D(2) dopamine receptorRattus norvegicus (Norway rat)0.003
WD repeat-containing protein 48Homo sapiens (human)7
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0022

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1

Other Studies

1 other study(ies) available for melagatran and flupenthixol

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008